NAII logo

NATURAL ALTERNATIVES INTL

NAIINASDAQ
πŸ† #4970 by market capUS Equity
$1.47β–Ό $0.20 (βˆ’13.53%)
πŸŒ™ After hours$1.49β–² 1.32%Regular close Β· extended-hours price shown
πŸ””
Track NAII
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 13.5%
7dβ–Ό 25.6%
14dβ–Ό 25.8%
30dβ–Ό 32.9%
ytdβ–Ό 58.3%
1yβ–Ό 50.3%
🏦Market Cap
$9M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+14.1%
Healthy
πŸ“ŠGross Margin
7.0%
Thin
πŸ’΅FCF Margin
-6.4%
Thin
βš–οΈP/S Ratio
0.1x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$1.46 – $1.48
52-Week Range
$1.73 – $4.96
Volume
$4.08B
Avg Volume
$3.88B
Shares Outstanding
6.3M
Next Earnings
Oct 17, 2026

Fundamentals Snapshot

Annual Revenue
$130M
Last Q Revenue
$35M
P/E Ratio
-0.7
P/S Ratio
0.1x
EPS (TTM)
$-2.39
Dividend Yield
0.00%
Dilution (1yr)
+1.5%

Why Investors Own NAII

  • βœ“High-growth profile β€” revenue up +17.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 30% gross margin and 28% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

NAII logo

NATURAL ALTERNATIVES INTL

NAII
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$130Mβ–² +14.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
7.2%β–² +18.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$9Mβ–² +1.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$2Mβ–Ό βˆ’151.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
6.0Mβ–² +1.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$103Mβ–Ό βˆ’$50M YoY
StockOtter Β· stockotter.space

About NATURAL ALTERNATIVES INTL

Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$1.77
β–² +20.6% Upside
High Target$2.10
Low Target$1.34
Based on 36 analysts

Latest News & Updates